Congresswoman Nancy Pelosi (D-Calif.) beat the stock market in 2025 with her investment portfolio posting gains once again.

TEM has surged 105% in a year on AI-driven growth, FDA clearances and improving margins, but GAAP losses still cloud the ...

By the close of trading, Tempus AI's stock price was up more than 4% after rising as much as 15% earlier in the day. Tempus ...

Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M ...

Tempus AI CEO Eric Lefkofsky presented at the JP Morgan Healthcare Conference to discuss how the company is practising ...

Tempus AI partners with NYU Langone Health and Northwestern Medicine to broaden access to genomic testing, enhancing ...

If you are wondering whether Tempus AI's current share price reflects its underlying worth, you are not alone. This article ...

Chicago artificial intelligence giant Tempus AI is showing it's operating in the black after 10 years and growing.

Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...

Tempus and NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock surged 12% Monday after the precision medicine technology company announced it achieved a record total contract value (TCV) exceeding $1.1 billion ...

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation's premier academic medical centers, today announced a multi-year strategic collaboration ...